Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Signaling Pathways

Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.


APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.


Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.

Items 10821-10830 of 10838

Page
per page
  1. Azathramycin
    BA1060 Azathramycin
    Summary: An antibiotic that targets the ribosome.
  2. Gamithromycin
    BA1074 Gamithromycin
    Summary: Gamithromycin is a macrolide antibiotic whose core biological activity is inhibition of bacterial protein synthesis, targeting the 50S subunit of the bacterial ribosome.
  3. Sulfamonomethoxine
    BA1078 Sulfamonomethoxine
    Summary: Broad-spectrum sulfonamide antibiotic whose core biological activity is inhibition of folic acid biosynthesis in bacteria and protozoa, targeting dihydropteroate synthase (DHPS).
  4. Tiamulin
    BA1083 Tiamulin
    Summary: Tiamulin (Thiamutilin) is a diterpene antibiotic widely used in pigs and poultry to control infectious diseases.
  5. Cefazedone
    BA1102 Cefazedone
    Summary: Cefazedone (Refosporen) is a first-generation cephalosporin broad-spectrum antibiotic. Its core bioactivity is inhibition of bacterial cell wall synthesis, and its target is bacterial penicillin-binding proteins (PBPs).
  6. Temafloxacin
    BA1108 Temafloxacin
    Summary: A fluoroquinolone broad-spectrum antibacterial agent whose core bioactivity is inhibition of bacterial DNA replication and transcription, targeting bacterial DNA gyrase (gyrA subunit) and topoisomerase IV (Topoisomerase IV).
  7. Novobiocin
    BA1116 Novobiocin
    Summary: Novobiocin (Albamycin) is an effective orally active antibiotic. Its targets include bacterial DNA gyrase (subunit B, inhibiting ATPase activity) and heat shock protein 90 (Hsp90, C-terminal nucleotide-binding site).
  8. Sisomicin
    BA1199 Sisomicin
    Summary: Sisomicin is a broad-spectrum aminoglycoside antibiotic produced by Micromonospora inyoensis. Its core bioactivity is inhibition of bacterial protein synthesis, targeting the 30S subunit of the bacterial ribosome.
  9. Propranolol
    BA1217 Propranolol
    Summary: Propranolol is a non-selective β-adrenergic receptor (β1AR/β2AR) blocker
  10. Gepotidacin
    BA1220 Gepotidacin
    Summary: A novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.

Items 10821-10830 of 10838

Page
per page